Jaguar Health, Inc. (JAGX) Financials
JAGX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 45.4 million | 44.0 million |
2023-06-30 | 52.2 million | 46.3 million |
2023-03-31 | 56.9 million | 49.3 million |
2022-12-31 | 47.5 million | 48.8 million |
JAGX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -6.8 million | 528000 |
2023-06-30 | -9.1 million | 527000 |
2023-03-31 | -9.9 million | 480000 |
2022-12-31 | -6.8 million | 497000 |
JAGX Net Income
No data available :(
JAGX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 3.2 million | - | 877000 |
2023-06-30 | 8.6 million | - | 1.0 million |
2023-03-31 | 14.4 million | - | 1.1 million |
2022-12-31 | 5.5 million | - | 1.2 million |
JAGX Shares Outstanding
JAGX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 6.1 million | 4.4 million | 637000 |
2023-06-30 | - | 4.3 million | 5.1 million | 878000 |
2023-03-31 | - | 4.8 million | 4.8 million | 1.9 million |
2022-12-31 | 361000 | 4.3 million | 3.0 million | 1.7 million |
JAGX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.8 million | 514000 |
2023-06-30 | 2.7 million | 491000 |
2023-03-31 | 2.0 million | 345000 |
2022-12-31 | 3.3 million | 495000 |
JAGX
Price: $0.18
52 week price:
Earnings Per Share: -0.87 USD
P/E Ratio: -0.11
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 617552
Ebitda: -16.5 millionMarket Capitalization: 20.9 million